Upsher-Smith Laboratories Adds ITI-111 (Nasal Midazolam) To CNS Development Pipeline
MAPLE GROVE, Minnesota, June 28, 2010 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. today announced an agreement with Ikano Therapeutics, Inc. to obtain exclusive global rights to ITI-111, Ikano's…